Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jan 08 02:51PM ET
70.97
Dollar change
-0.70
Percentage change
-0.98
%
IndexS&P 500 P/E29.06 EPS (ttm)2.44 Insider Own1.35% Shs Outstand125.15M Perf Week2.56%
Market Cap8.85B Forward P/E13.74 EPS next Y5.17 Insider Trans-2.11% Shs Float123.00M Perf Month-2.78%
Income314.00M PEG3.44 EPS next Q1.23 Inst Own106.58% Short Float5.56% Perf Quarter1.40%
Sales12.50B P/S0.71 EPS this Y6.08% Inst Trans3.50% Short Ratio4.49 Perf Half Y10.56%
Book/sh27.99 P/B2.54 EPS next Y8.21% ROA3.08% Short Interest6.84M Perf Year-5.86%
Cash/sh1.01 P/C70.23 EPS next 5Y8.44% ROE8.78% 52W Range63.67 - 82.63 Perf YTD2.56%
Dividend Est.- P/FCF19.19 EPS past 5Y-1.96% ROI5.54% 52W High-14.11% Beta0.89
Dividend TTM- Quick Ratio0.82 Sales past 5Y5.86% Gross Margin29.62% 52W Low11.47% ATR (14)1.93
Dividend Ex-Date- Current Ratio1.42 EPS Y/Y TTM-27.46% Oper. Margin4.79% RSI (14)47.64 Volatility2.21% 2.69%
Employees25000 Debt/Eq0.85 Sales Y/Y TTM-1.53% Profit Margin2.51% Recom2.53 Target Price76.08
Option/ShortYes / Yes LT Debt/Eq0.62 EPS Q/Q-25.24% Payout0.00% Rel Volume0.30 Prev Close71.67
Sales Surprise-1.90% EPS Surprise4.29% Sales Q/Q0.38% EarningsNov 05 BMO Avg Volume1.52M Price70.97
SMA20-1.07% SMA50-1.48% SMA2000.55% Trades Volume385,212 Change-0.98%
Date Action Analyst Rating Change Price Target Change
Jan-06-25Upgrade BofA Securities Underperform → Buy $69 → $84
Dec-04-24Initiated Mizuho Neutral $75
Jul-22-24Upgrade Robert W. Baird Neutral → Outperform $81 → $92
Feb-26-24Initiated Leerink Partners Market Perform $78
Dec-12-23Upgrade JP Morgan Neutral → Overweight $71 → $82
Nov-10-23Upgrade Stifel Hold → Buy $70
Aug-08-22Upgrade UBS Sell → Neutral $80
Jul-21-22Downgrade Goldman Buy → Neutral $93 → $85
Jun-14-22Downgrade Robert W. Baird Outperform → Neutral $103 → $88
May-13-22Resumed Credit Suisse Outperform $100
Jan-07-25 12:03PM
Dec-26-24 09:00PM
Dec-17-24 06:30AM
Dec-13-24 09:40AM
Dec-12-24 02:32PM
11:30AM Loading…
Dec-05-24 11:30AM
Nov-26-24 09:40AM
Nov-23-24 05:00AM
Nov-21-24 06:30AM
03:59AM
Nov-20-24 06:30AM
Nov-18-24 04:51PM
01:35PM
Nov-16-24 10:12AM
Nov-06-24 02:15AM
01:46AM Loading…
01:46AM
Nov-05-24 12:11PM
09:30AM
07:11AM
07:10AM
06:10AM
06:00AM
Oct-31-24 01:23PM
09:15AM
Oct-29-24 10:01AM
Oct-24-24 06:30AM
Oct-18-24 12:10PM
Oct-17-24 08:00AM
Oct-08-24 05:33PM
Oct-02-24 04:32PM
11:00AM Loading…
Oct-01-24 11:00AM
06:30AM
Sep-30-24 06:30AM
Sep-26-24 03:00PM
06:30AM
Sep-25-24 07:30AM
06:27AM
Sep-17-24 06:30AM
Sep-12-24 06:30AM
Sep-05-24 11:31AM
07:58AM
Aug-29-24 06:30AM
Aug-23-24 11:35AM
Aug-19-24 09:00AM
08:25AM
Aug-15-24 06:30AM
Aug-12-24 06:30AM
Aug-07-24 06:32AM
03:04AM
Aug-06-24 05:32PM
09:43AM
09:30AM
08:57AM
07:10AM
06:11AM
06:00AM
Aug-05-24 09:16AM
09:05AM
Jul-31-24 06:30AM
Jul-30-24 10:01AM
Jul-26-24 09:50AM
Jul-23-24 09:59AM
Jul-22-24 09:40AM
Jul-18-24 03:33AM
Jul-17-24 05:41PM
Jul-15-24 03:57AM
Jul-12-24 09:33AM
Jul-10-24 04:00PM
Jul-08-24 06:30AM
Jul-05-24 11:30AM
Jul-01-24 06:16AM
Jun-25-24 06:51AM
Jun-12-24 09:40AM
Jun-10-24 07:19AM
07:00AM
Jun-08-24 02:35AM
Jun-06-24 11:31AM
11:25AM
May-27-24 09:40AM
May-21-24 06:30AM
May-20-24 09:50AM
May-17-24 08:10AM
06:30AM
May-16-24 08:41AM
May-15-24 09:06AM
May-13-24 10:40AM
06:30AM
May-08-24 12:54PM
10:23AM
09:40AM
07:40AM
06:19AM
03:28AM
01:14AM
May-07-24 10:55AM
09:30AM
08:58AM
08:06AM
07:32AM
07:10AM
Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, laboratory, small and large equipment repair services, branded and generic pharmaceuticals, vaccines, surgical, diagnostic tests, infection-control products, and vitamins. The Technology and Value-Added Services segment offers financial on a non-recourse basis, network, and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ettinger Michael SEVP & Chief Operating OfficerNov 18 '24Sale75.0012,240918,00087,706Nov 20 04:15 PM
Ettinger Michael SOfficerNov 18 '24Proposed Sale75.0012,240918,000Nov 18 03:05 PM
McGlynn LoreleiSVP, Chief Human Res. OfficerSep 06 '24Sale69.3021,0351,457,72671,833Sep 09 05:19 PM
McGlynn LoreleiOfficerSep 06 '24Proposed Sale69.9321,0351,470,998Sep 06 11:38 AM
MLOTEK MARK EEVP, Chief Strategic OfficerAug 14 '24Sale69.123,000207,36087,851Aug 15 04:36 PM
MLOTEK MARK EOfficerAug 14 '24Proposed Sale69.123,000207,353Aug 14 12:27 PM
Siegel WalterSr. VP & Chief Legal OfficerJun 06 '24Sale69.474,134287,18939,526Jun 07 04:15 PM
Connett Bradford CCEO, NA Distribution GroupMar 20 '24Sale74.286,430477,62073,108Mar 21 04:18 PM
BRESLAWSKI JAMES PVice Chairman, PresidentMar 18 '24Sale74.372,907216,194209,562Mar 19 04:11 PM
LASKAWY PHILIP ADirectorMar 05 '24Sale76.294,278326,36924,565Mar 06 04:54 PM
KUEHN KURT PDirectorMar 01 '24Sale77.071,582121,92513,598Mar 05 04:52 PM
BRESLAWSKI JAMES PVice Chairman, PresidentMar 04 '24Sale76.502,907222,386212,469Mar 05 04:27 PM